Problems of toxicity of anticancer drugs
Young, R.S.
Federation Proceedings 38(1): 113-114
1979
ISSN/ISBN: 0014-9446 PMID: 759231 Document Number: 141030
Document emailed within 1 workday
Related Documents
Bruckner, H.W.; Spigelman, M. 1988: Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy Mount Sinai Journal of Medicine new York 55(5): 390-394Brooks, P.M.; Day, R.O. 1995: Toxicity of antirheumatic drugs. Toxicity Workgroup Leaders Journal of Rheumatology 22(5): 998-999
Ben Aïssa, A.; George, A-C.; El M'Rabet, F.Z.; Mach, N.; Dietrich, P-Y.; Pechère-Bertschi, A. 2011: Anticancer drugs under pressure Revue Medicale Suisse 7(308): 1761-1766
Bénard, J.; Rixe, O. 1996: Resistance to anticancer drugs Presse Medicale 25(35): 1724-1730
Plunkett, W.; Gandhi, V. 1993: Cellular pharmacodynamics of anticancer drugs Seminars in Oncology 20(1): 50-63
Fattoruso, S.I.S.; Di Lauro, L.; Conti, F.; Amodio, A.; Lopez, M. 2008: Target selectivity of anticancer drugs La Clinica Terapeutica 159(3): 189-206
Rosenthal, R.C.; Michalski, D. 1991: Storage of expensive anticancer drugs Journal of the American Veterinary Medical Association 198(1): 144-146
Brooks, P.M. 1995: The toxicity of nonsteroidal antiinflammatory drugs and antirheumatic drugs: an introduction Journal of Rheumatology 22(5): 982
Tsukagoshi, S. 1993: Recent development of new anticancer drugs in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 51(7): 1923-1929
Schmähl, D. 1986: Carcinogenicity of anticancer drugs and especially alkylating agents Iarc Scientific Publications 78: 29-35
Ogawa, M. 1983: Current clinical status of new anticancer drugs Gan no Rinsho. Japan Journal of Cancer Clinics 29(10): 1049-1052
Piuhola, J.; Tenhunen, O.; Kerkelä, R. 2015: Adverse cardiac effects associated with anticancer drugs Duodecim; Laaketieteellinen Aikakauskirja 131(5): 441-447
Collins, J.M. 1988: Improving the use of anticancer drugs: clinical pharmacokinetic approaches Israel Journal of Medical Sciences 24(9-10): 483-487
Gokhale, S.V.; Ganu, U.K.; Ambaye, R.Y. 1985: Effects of anticancer drugs on folate disposition and excretion Journal of Postgraduate Medicine 31(3): 123-127
Yokoyama, M.; Okano, T.; Sakurai, Y.; Ekimoto, H.; Shibazaki, C.; Kataoka, K. 1991: Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood Cancer Research 51(12): 3229-3236
Harguindey, S.; Arranz, J.L.; Wahl, M.L.; Orive, G.; Reshkin, S.J. 2009: Proton transport inhibitors as potentially selective anticancer drugs Anticancer Research 29(6): 2127-2136
Gmeiner, W.H. 1998: NMR spectroscopy as a tool to investigate the structural basis of anticancer drugs Current Medicinal Chemistry 5(2): 115-135
Baryshnikov, A.I. 2012: Nanostructured liposomal systems as transport agents for anticancer drugs Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 3: 23-31
Matsuoka, T.; Yoshimura, T.; Asano, H.; Adachi, S.; Okada, K.; Yasuda, T. 2013: Induction of allergic reactions by anticancer drugs in outpatient chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(2): 209-214
Powis, G. 1994: Recent advances in the development of anticancer drugs that act against signalling pathways Tumori 80(2): 69-87